Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-25-000025

Bylaws or fiscal year change

  • Item 5.03 Amendments to articles or bylaws; change in fiscal year

From the SEC's structured data for this filing

Loading kros-20250305.htm…